HC-2024-0086-V386

Major variation for application HC-2024-0086. Major variation: Formulation Change for Ozanemolistat — critical change

Variation Number
HC-2024-0086-V386
Type
Major
Application
HC-2024-0086
Change
CHG-2023-0086
Status
Failed
Fee
€11,889
Submitted
2023-02-25
Approved
—
Description

Major variation: Formulation Change for Ozanemolistat — critical change